First human tests begin for new drug candidate
NCT ID NCT06435442
Summary
This is an early-stage safety study for a new drug called epaminurad. It will test how safe the drug is, how the body processes it, and if it interacts with a common pain reliever (naproxen). The study involves 48 healthy volunteers to gather initial data before testing in patients.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Seoul National University Hospital
Seoul, South Korea
Conditions
Explore the condition pages connected to this study.